You are here: Industry Insights > nasal spray

News List

Cipla receives final approval for generic version of Migranal with a Competitive Generic Therapy Des expresspharma
May 21, 2020
Cipla is the “first approved applicant” for such CGT and, is therefore, eligible for 180 days of CGT exclusivity which will begin to run from the commercial marketing of Cipla’s product.
University of Waterloo to develop nasal vaccine for Covid-19 pharmaceutical-technology
April 20, 2020
University of Waterloo researchers in Canada are developing a DNA-based vaccine candidate that can be given via nasal route to protect from Covid-19 infection.
Janssen’s esketamine nasal spray approved in the EU pharmaceutical-technology
December 24, 2019
The European Commission (EC) has approved Johnson & Johnson subsidiary Janssen’s Spravato (esketamine) nasal spray for treatment-resistant major depressive disorder.
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal® Nasal Spray americanpharmaceuticalreview
August 23, 2019
Perrigo Company has settled its Hatch-Waxman litigation relating to Nascobal® (Cyanocobalamin) Nasal Spray brought by Endo Pharmaceuticals Inc. Terms of the settlement are confidential.
EmphyCorp FDA Submission for Rx New Non-Steroidal Nasal Spray for Pulmonary Fibrosis americanpharmaceuticalreview
August 16, 2019
mphyCorp announced the completion of a clinical trial to define medical endpoints as requested by the FDA for the NDA marketing application in patients with Pulmonary Fibrosis, under its Orphan Drug Designations for ...
FDA Approves First Generic Naloxone Nasal Spray to Treat Opioid Overdose drugs
April 22, 2019
FDA Approves First Generic Naloxone Nasal Spray to Treat Opioid Overdose
FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic worldpharmanews
March 07, 2019
The U.S. Food and Drug Administration (FDA) today approved Spravato (esketamine) nasal spray
After Opioid OD, Most Patients Can Leave Hospital in an Hour drugs
January 04, 2019
People who overdose on opioids can often be saved quickly with a dose of naloxone, but it hasn't been clear how long someone should be kept in the hospital after being revived.....
Janssen files nasal spray for depression pharmatimes
October 12, 2018
Janssen has submitted a marketing application to the European Medicines Agency (EMA) seeking approval of investigational nasal spray esketamine for the treatment of major depressive disorder.
Janssen Announces Mixed Results of Esketamine Nasal Spray Study americanpharmaceuticalreview
September 25, 2018
Janssen Pharmaceutical announced results from a Phase 3 clinical study of the investigational product esketamine nasal spray in patients with treatment-resistant depression.

Previous page 1 2 3 4 Next page